Class III — Low Risk

Low risk — use of or exposure to this product is not likely to cause adverse health consequences.

Trinity Biotech HbA1c (GHb) Contorls Kit Recalled by Primus Corporation dba Trinity Biotech Due to The Control Level I material value was showing...

Date: October 5, 2021
Company: Primus Corporation dba Trinity Biotech
Status: Terminated
Source: FDA (Device)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact Primus Corporation dba Trinity Biotech directly.

Affected Products

Trinity Biotech HbA1c (GHb) Contorls Kit, 500uL (Levels I & II), REF 01-04-0020, Part number 05-01-0040B, A1c analysis

Quantity: 182 kits

Why Was This Recalled?

The Control Level I material value was showing results exceeding the upper limit of the acceptable range after a period of three (3) months. Additionally, per the firm, the unacceptable Control Level 1 value results in the Analyzer generating an error code which stops further testing and nullifies associated patient samples, resulting in a delay in patient results and a potential delay in therapeutic modifications.

Where Was This Sold?

Turkey, India, Romania, Thailand, Vietnam, S. Korea, Peru, Pakistan Austria, UAE, Chile, Italy.

About Primus Corporation dba Trinity Biotech

Primus Corporation dba Trinity Biotech has 2 total recalls tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Device). Last updated March 26, 2026. View original report